- Home
- GBX vs ELVN Comparison
GBX vs ELVN Comparison
Compare GBX & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBX
- ELVN
- Stock Information
- Founded
- GBX 1974
- ELVN 2016
- Country
- GBX United States
- ELVN United States
- Employees
- GBX N/A
- ELVN N/A
- Industry
- GBX Railroads
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- GBX Industrials
- ELVN Health Care
- Exchange
- GBX Nasdaq
- ELVN Nasdaq
- Market Cap
- GBX 1.4B
- ELVN 1.2B
- IPO Year
- GBX N/A
- ELVN 2020
- Fundamental
- Price
- GBX $46.75
- ELVN $20.16
- Analyst Decision
- GBX Hold
- ELVN Strong Buy
- Analyst Count
- GBX 2
- ELVN 5
- Target Price
- GBX $59.50
- ELVN $41.20
- AVG Volume (30 Days)
- GBX 424.5K
- ELVN 327.6K
- Earning Date
- GBX 07-01-2025
- ELVN 08-13-2025
- Dividend Yield
- GBX 2.77%
- ELVN N/A
- EPS Growth
- GBX 88.14
- ELVN N/A
- EPS
- GBX 7.10
- ELVN N/A
- Revenue
- GBX $3,533,700,000.00
- ELVN N/A
- Revenue This Year
- GBX N/A
- ELVN N/A
- Revenue Next Year
- GBX N/A
- ELVN N/A
- P/E Ratio
- GBX $6.51
- ELVN N/A
- Revenue Growth
- GBX 0.70
- ELVN N/A
- 52 Week Low
- GBX $37.77
- ELVN $13.30
- 52 Week High
- GBX $71.06
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- GBX 46.90
- ELVN 49.50
- Support Level
- GBX $44.44
- ELVN $18.13
- Resistance Level
- GBX $47.70
- ELVN $20.26
- Average True Range (ATR)
- GBX 1.03
- ELVN 1.24
- MACD
- GBX 0.15
- ELVN 0.01
- Stochastic Oscillator
- GBX 64.80
- ELVN 59.11
About GBX Greenbrier Companies Inc. (The)
Greenbrier Companies Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe, marine barges in North America and provides wheel services, railcar refurbishment, and parts, leasing and other services to the railroad. Its segments include Manufacturing, Maintenance Services and Leasing & Management Services. The company generates a majority of its revenue from the manufacturing segment. Geographically, it derives a majority of its revenue from the United States.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.